2nd Quarter - Report — CEPHEID for CEPHEID (2009)

Firm

CEPHEID

Client

CEPHEID

Income

—

Expenses

$60,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

See page 3 HR 1 American Recovery and Reinvestment Act of 2009 HR 805 / S 1028 Strengthening America's Public Health System Act H.R. 1105 FY 2009 Omnibus Appropriations Act HR 1321 Healthy Americans Act HR 1452 Medicare Clinical Diagnostic Laboratory Fee Schedule Modernization Act of 2009 HR 1699 / S 1220 Patient Access to Critical Lab Tests Act HR 2502 Comparative Effectiveness Research Act of 2009 HR 2824 Doctor-Patient Relationship and Research Protection Act HR 2937/ S 1305 MRSA Infection Prevention and Patient Protection Act HR 3104 Healthy Hospitals Act of 2009 HR 3002 / S 1259 PATIENTS Act of 2009 S 1208 Strengthening America's Public Health System Act S 1213 Patient-Centered Outcomes Research Act of 2009 S 1220 Patient Access to Critical Lab Tests Act S 1299 Worker Infection Protection Act

Lobbyist	Covered position, as disclosed
HALLIE CHRISTINE LEWIS	Manager, Government Relations
MICHELE M SCHOONMAKER	Director, Government Affairs

Contacted: Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Agency for Healthcare Research & Quality (AHRQ); Medicare Payment Advisory Commission (MedPAC); HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC); Natl Institutes of Health (NIH); SENATE; Health & Human Services, Dept of (HHS)

Bills named: H.R. 3002 (111th), H.R. 2824 (111th), H.R. 805 (111th), H.R. 1321 (111th), H.R. 2502 (111th), H.R. 1699 (111th), H.R. 1 (111th), H.R. 2937 (111th), H.R. 3104 (111th), H.R. 1452 (111th), H.R. 1105 (111th)

Medical/Disease Research/Clinical Labs MED

See page 5 HR 1 American Recovery and Reinvestment Act of 2009 HR 805 / S 1028 Strengthening America's Public Health System Act H.R. 1105 FY 2009 Omnibus Appropriations Act HR 1321 Healthy Americans Act HR 1452 Medicare Clinical Diagnostic Laboratory Fee Schedule Modernization Act of 2009 HR 1699 / S 1220 Patient Access to Critical Lab Tests Act HR 2502 Comparative Effectiveness Research Act of 2009 HR 2824 Doctor-Patient Relationship and Research Protection Act HR 2937/ S 1305 MRSA Infection Prevention and Patient Protection Act HR 3104 Healthy Hospitals Act of 2009 HR 3002 / S 1259 PATIENTS Act of 2009 S 1208 Strengthening America's Public Health System Act S 1213 Patient-Centered Outcomes Research Act of 2009 S 1220 Patient Access to Critical Lab Tests Act S 1299 Worker Infection Protection Act

Lobbyist	Covered position, as disclosed
HALLIE CHRISTINE LEWIS	Manager, Government Relations
MICHELE M SCHOONMAKER	Director, Government Affairs

Contacted: SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Medicare Payment Advisory Commission (MedPAC); Centers For Disease Control & Prevention (CDC); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Natl Institutes of Health (NIH); Agency for Healthcare Research & Quality (AHRQ)

Bills named: H.R. 2502 (111th), H.R. 1699 (111th), H.R. 1105 (111th), H.R. 3104 (111th), H.R. 805 (111th), H.R. 1321 (111th), H.R. 1452 (111th), H.R. 2824 (111th), H.R. 1 (111th), H.R. 2937 (111th), H.R. 3002 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.